MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10).
For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia Extends Decline To 7.3%, Biggest Drop Since April 2025
- Kelly Services (KELYA) Misses Q3 EPS by 5c
- Hut 8 Mining Corp. (HUT) PT Lowered to $165 at StoneX
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
